4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001636178-26-000007
CFO AND TREASURER sold 10,000 shares at an average $558.40 ($5,583,999)
- CFO AND TREASURER acquired 10,000 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
EDGEMOND JAMES · CFO AND TREASURER
Table I: Non-derivative
14 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-06 | Exercise or conversion : show line 1 in the form 10b5-1 | +10,000 | $135.42 | $1,354,200 | 28,876 | D |
| 2026-04-06 | Sale : show line 2 in the form 10b5-1 | −120 | $552.78 | $66,334 | 28,756 | D |
| 2026-04-06 | Sale : show line 3 in the form 10b5-1 | −437 | $553.97 | $242,084 | 28,319 | D |
| 2026-04-06 | Sale : show line 4 in the form 10b5-1 | −1,158 | $555.21 | $642,937 | 27,161 | D |
| 2026-04-06 | Sale : show line 5 in the form 10b5-1 | −1,205 | $556.06 | $670,052 | 25,956 | D |
| 2026-04-06 | Sale : show line 6 in the form 10b5-1 | −1,840 | $557.19 | $1,025,229 | 24,116 | D |
| 2026-04-06 | Sale : show line 7 in the form 10b5-1 | −1,679 | $558.31 | $937,409 | 22,437 | D |
| 2026-04-06 | Sale : show line 8 in the form 10b5-1 | −860 | $559.47 | $481,142 | 21,577 | D |
| Open-market sales · 10,000 sh · avg $558.40 · $5,583,999 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-06 | Exercise or conversion : show line 15 in the form 10b5-1 Stock Option | −10,000 | 112,500 | D |
Loading xslF345X06/primarydocument.xml…